Altamira Therapeutics Ltd. Annual stock financials by MarketWatch. View the latest CYTOF financial statements, income statements and financial ratios.
SOUTH SAN FRANCISCO, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive ...
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences ...
Owing to its complexity and interactions with peripheral cells, the brain is a difficult organ to study. Scientists require sensitive, high-dimensional techniques, such as cytometry by time of flight ...
Using cytometry by time of flight (CyTOF) technology, researchers measure multiple parameters for comprehensive cell phenotyping and functional analyses. This capability is especially important when ...
12-chemokine gene expression score in breast cancer patients treated with neoadjuvant chemotherapy. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include ...
SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...
Lack of association of immune checkpoint protein expression with T stage or stage grouping in colorectal cancer (CRC): A tissue microarray (TMA) based analysis of clinical data.
SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results